On 7 October, the Indian health authorities charged two pharmaceutical laboratories with exporting falsified diabetic medicines (metformin hydrochloride) to Bangladesh, Brazil, Mexico and Pakistan. The Wanbury laboratory had an export licence for 650,000 tonnes per month but a production capacity of 350,000 tonnes only. To meet the demand, Wanbury purchased the remaining 300,000 tonnes from Pharmaceutical Products of India Limited (PPIL) which did not have an export licence. Wanbury would then re-label the PPIL medicines as Wanbury products, without any quality checks, and then export to the clients. Both companies are believed to have been exporting almost $1m worth of fake medicines every month, for years.
Source : www.securingindustry.comBack to previous